Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies

BACKGROUND: To assess the efficacy and safety of treatment with abiraterone acetate (AA) in chemotherapy-naïve men with metastatic castration-resistant prostate cancer (mCRPC) in the ‘real-life’ setting. METHODS: Data acquisition on the outcomes of the use of AA in chemotherapy-naive patients with m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Urol
Autors principals: Marchioni, Michele, Sountoulides, Petros, Bada, Maida, Rapisarda, Sebastiano, De Nunzio, Cosimo, Tamburro, Fabiola Raffaella, Schips, Luigi, Cindolo, Luca
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Systematic Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120185/
https://ncbi.nlm.nih.gov/pubmed/30186368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287218786160
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars